Powering Progress to Save Lives

Sharon Belvin

Melanoma

Over 15 years cancer-free, Sharon was one of the first patients to be treated successfully with ipilimumab

Brendan Connors

Melanoma

After successfully finishing a combination of immunotherapies for metastatic melanoma, 32-year-old Brendan seized any opportunity for adventure.

Janie Ferling

Melanoma

When Janie, a mother from L.A., learned that a lump in her neck was malignant melanoma, she was determined to do whatever she could to be around as long as possible for her son.

Maureen O'Grady

Lung Cancer

In 2010, Maureen participated in a clinical trial of a new immunotherapy drug called nivolumab to treat her stage 4 lung cancer.

Judy Perkins

Breast Cancer

Judy made headlines as the first metastatic breast cancer patient successfully treated with TIL therapy.

Karen Peterson

Breast Cancer

Karen is proud to be Patient #1 in a combination immunotherapy clinical trial for metastatic triple-negative breast cancer.

Rikki Rockett

Head and Neck Cancer

The drummer for Poison enrolled in an immunotherapy clinical trial for oral cancer.

Emily Whitehead

Leukemia

At only 6-years-old, Emily faced a life-threatening recurrence of leukemia. Determined to save her life, her parents enrolled her in a clinical trial.

James P. Allison, Ph.D.

The University of Texas at MD Anderson Cancer Center

CRI Scientific Advisory Council director James Allison explains why "taking the brakes off" T cells is a good way to fight cancer.

Ian H. Frazer, AC, FRS, FAA

The University of Queensland, Australia

The CRI Clinical Investigator is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.

Carl H. June, M.D.

University of Pennsylvania

Pancreatic cancer patients will be enrolled in a clinical trial of a new immunotherapy that harnesses the immune system’s ability to fight pancreatic cancer.

Hyam I. Levitsky, M.D.

Johns Hopkins University

Dr. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.

Kunle Odunsi, M.D., Ph.D.

Roswell Park Cancer Institute

CRI physician-scientist Kunle Odunsi, M.D., Ph.D., is leading the way in cancer immunotherapy for ovarian cancer.

Corrie Painter, Ph.D.

University of Massachusetts

Angiosarcoma patient and CRI postdoctoral fellow Dr. Corrie Painter is studying how immune cells in zebrafish can fight against hers and other cancers.

David A. Reardon, M.D.

Dana-Farber Cancer Institute

For glioblastoma, the most dangerous and aggressive form of brain cancer, fewer than 10 percent of patients survive more than 5 years. Dr. Reardon wants to change that.

Antoni Ribas, M.D., Ph.D.

University of California, Los Angeles

Dr. Ribas, of UCLA, discusses his latest immunotherapy clinical trials and how it'll transform cancer treatment.

Robert Schreiber, Ph.D.

Washington University School of Medicine

By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has brought us closer to cures for cancer

Padmanee Sharma, M.D., Ph.D.

The University of Texas at MD Anderson Cancer Center

Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.

Ralph Steinman, M.D.

The Rockefeller University

Dr. Steinman discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.

Jedd D. Wolchok, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

The leading immunotherapy expert knows better than almost anyone what clinical trials can do for patients.

Mary Jo Bramson

Mary Jo and her friends organized fundraisers over the next 10 years for CRI, raising more than $687,000 in total.

Mark E. Fischbach aka Markiplier

Since 2013, Markiplier has creatively leveraged his 50.5 million followers across social media through fun events to raise over $500,000 for CRI’s programs and increase awareness for medical research

Jessica Haze

A popular makeup artist's goal to raise $100,000 in 100 days for CRI.

Keith Landesman, M.D.

Cardiologist Dr. Landesman tragically lost his life to cancer in 2008. To honor his memory, his family hosts their annual golf tournament and silent auction to support cancer research.

Jacques C. Nordeman

CRI trustee Jacques Nordeman has been steering the course against cancer for more than three decades.

DJ Eric Prydz

The famous DJ donated ticket sales from his concerts to CRI in honor of super-fan James Lillo.

Sherri Thompson

Sherri doesn't know a single family that hasn't been touched by cancer. So when she learned of CRI's work, she wanted to do something big and held a benefit concert.

Two Minutes to Late Night

The world’s only heavy metal-themed talk show raised money with an epic cover in honor of Neil Peart.